Quantum Healthcare Income Statement

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	13.19	13.06	12.69	13.08	9.37	-
Revenue Growth (YoY)	2.54%	2.99%	-3.03%	39.63%	-	-
Cost of Revenue	7.24	7.13	7.03	7.32	5.02	-
Gross Profit	5.95	5.93	5.66	5.76	4.35	-
Selling, General & Admin	6.48	6.46	6.89	8.73	6.61	3.26
Research & Development	-	-	-	-	0.74	-
Other Operating Expenses	-0.21	-0.21	-0.16	-0.18	-0.09	0
Operating Expenses	6.27	6.24	6.73	8.55	7.27	3.26
Operating Income	-0.31	-0.31	-1.08	-2.79	-2.92	-3.26
Interest Expense	-0.33	-0.35	-0.46	-0.49	-0.45	-0.03
Currency Exchange Gain (Loss)	-	-	-	-	-0	-0.04
EBT Excluding Unusual Items	-0.64	-0.66	-1.54	-3.28	-3.37	-3.34
Impairment of Goodwill	-2.19	-2.19	-1.01	-	-4.63	-
Gain (Loss) on Sale of Assets	0	0	0.02	-	-0.79	0.14
Asset Writedown	-	-	-	-	-	-2.11
Other Unusual Items	0	0	-	-	-	-
Pretax Income	-2.83	-2.85	-2.52	-3.28	-8.78	-5.31
Income Tax Expense	0.07	0.07	0.04	0.1	0.12	-
Earnings From Continuing Operations	-2.9	-2.91	-2.56	-3.38	-8.9	-5.31
Minority Interest in Earnings	0.08	0.17	0.33	-0.24	-0.17	0.03
Net Income	-2.82	-2.74	-2.23	-3.62	-9.07	-5.28
Net Income to Common	-2.82	-2.74	-2.23	-3.62	-9.07	-5.28
Shares Outstanding (Basic)	9,443	8,289	7,947	7,327	6,751	2,260
Shares Outstanding (Diluted)	9,443	8,289	7,947	7,327	6,751	2,260
Shares Change (YoY)	17.77%	4.30%	8.46%	8.53%	198.73%	4.08%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	1.61	1.89	1.1	-0.93	-2.23	-1.3
Free Cash Flow Per Share	-	-	-	-	-	-0.00
Gross Margin	45.13%	45.41%	44.60%	44.03%	46.42%	-
Operating Margin	-2.38%	-2.39%	-8.48%	-21.34%	-31.14%	-
Profit Margin	-21.35%	-21.00%	-17.61%	-27.68%	-96.78%	-
Free Cash Flow Margin	12.19%	14.47%	8.63%	-7.08%	-23.76%	-
EBITDA	0.27	0.24	-0.56	-2.31	-2.59	-3.17
EBITDA Margin	2.08%	1.80%	-4.38%	-17.68%	-27.62%	-
D&A For EBITDA	0.59	0.55	0.52	0.48	0.33	0.09
EBIT	-0.31	-0.31	-1.08	-2.79	-2.92	-3.26
EBIT Margin	-2.38%	-2.39%	-8.48%	-21.34%	-31.14%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.